Top Pharmaceutical Exporting Company in India

With deep industry expertise and a strong global network, we manage sourcing, logistics, and compliance with precision.

Blogs

Explore insights, trends, and ideas in branding, marketing, design, and digital growth. Stay updated with practical strategies, creative inspiration, and industry knowledge to help your business grow smarter and stronger.

India exports pharmaceuticals to over 200 countries worldwide, and the figure is growing every year. We at Srindhya Global are involved in the sourcing aspect of this business. We help our clients in procuring GMP certified pharmaceutical products, including finished dosage formulations, APIs and raw materials from India to buyers and distributors overseas. So questions we hear about who, what and where make up India’s pharma export base come up frequently. 

In this article, we discuss what qualities define a successful pharmaceutical exporter in India. We highlight who the largest exporters are by number as well as by revenue and what a buyer needs to know before placing an order related to the export of pharmaceutical products from India.

India’s Pharma Export Numbers, in Brief

A few figures set the stage:

  • India’s pharmaceutical exports touched USD 30.47 billion in FY 2024-25, up 9.4% from the year before.
  • Drug formulations and biologicals made up about 75% of that total, at close to USD 22.9 billion, with bulk drugs and vaccines making up the rest.
  • The US alone took roughly a third of all Indian pharma exports, with the UK, Brazil, France, and South Africa also ranking among the top buyer countries.
  • India stands as the world’s third-largest drug producer by volume and supplies about 20% of the world’s generic medicines.
  • More than 3,000 companies and over 10,500 manufacturing sites run this industry, turning out over 60,000 generic brands across 60 therapy areas.

With those numbers in mind, here’s a look at the companies driving the bulk of this trade.

Top Pharmaceutical Exporting Companies in India

1. Srindhya Global

Srindhya Global sits at the top of India’s pharma sector by both revenue and market value, with net good annual sales. Its product range covers agricultural, neurological, heart, and eye care drugs, and the company runs plants and pharmaceutical exporters in India.

2. Dr. Reddy’s Laboratories

Founded in 1984, Dr. Reddy’s has built a name in branded generics and, more recently, biosimilars. Revenue for the company runs above ₹34,600 crore, and it has filed for first-to-file drug approvals in the US market well ahead of several patent cliffs.

3. Cipla

Cipla carries over 1,500 products in its line-up and holds a strong spot in the US, Europe, and several developing markets. Its consumer health and biosimilar arms have added to a revenue base of around ₹28,300 crore.

4. Aurobindo Pharma

Aurobindo runs 29 manufacturing sites worldwide and has built a wide base in complex generics and biosimilars. Its supply chain covers everything from active pharmaceutical ingredients through to finished dose forms, which keeps it close to the top of the export list.

5. Lupin

Lupin holds a large share in cardiovascular, diabetes, and respiratory drugs, with revenue near ₹24,700 crore. The company also runs a sizeable API manufacturing base that feeds both its own formulations and outside buyers.

6. Zydus Lifesciences

Formerly known as Cadila, Zydus has built out a broad generics and biosimilars business, alongside a growing consumer wellness line. The company counts among India’s top five pharma names by both revenue and market value.

7. Torrent Pharmaceuticals

Torrent stands out for its branded generics business across 50-plus countries, with a strong hold in cardiovascular, central nervous system, and women’s health drugs. It was the first Indian company to reach the top prescription market share in both Germany and Brazil.

8. Biocon

Biocon leads India’s biosimilar segment, with approvals for products like trastuzumab, bevacizumab, and insulin biosimilars in regulated markets. As global demand for biosimilars grows, Biocon’s export book keeps expanding alongside it.

9. Divi’s Laboratories

Divi’s focuses on active pharmaceutical ingredients and drug intermediates rather than finished formulations, supplying many of the world’s largest pharma companies with the raw building blocks for their own products.

10. Glenmark Pharmaceuticals

Glenmark runs a mixed business across generics, specialty drugs, and active ingredients, with a strong footprint in respiratory and dermatology treatments across regulated and semi-regulated markets alike.

What Sets a Strong Pharma Exporting Company Apart

Looking across this list, a few traits show up again and again:

  • Regulatory approvals in major markets. USFDA, UK MHRA, EU GMP, and WHO-GMP certifications open doors that unregistered manufacturers simply cannot access.
  • A wide product range. Companies that cover formulations, APIs, and biosimilars can serve more buyer needs without a change of supplier.
  • Manufacturing scale. Multiple plants across different states or countries reduce the risk of a single-site shutdown disrupting supply.
  • A track record in regulated markets. More than 60% of India’s pharma exports go to tightly regulated markets, and companies that hold up under that scrutiny tend to hold up everywhere else too.

Registration and Compliance for Pharma Exports from India

Anyone exporting pharmaceutical products out of India needs to clear a few gates:

  1. Get an Import Export Code (IEC) from the DGFT.
  2. Register with the Pharmaceuticals Export Promotion Council of India (Pharmexcil), the government body set up to back pharma exports and connect exporters with buyers abroad through trade shows and market data.
  3. Hold a valid manufacturing license and GMP certification from the Central Drugs Standard Control Organisation (CDSCO) or the relevant state authority.
  4. Meet the specific registration rules of the destination country, such as an ANDA filing for the US or a Certificate of Pharmaceutical Product for many other markets.
  5. Keep batch records, stability data, and quality control reports ready for inspection at any point.

Pharmexcil also helps members claim Market Access Initiative benefits and organises trade delegations, which smaller exporters often rely on to reach new buyer networks abroad.

Sourcing Pharma Products from India as a Buyer

Buying straight from a large manufacturer is never the easiest option for the buyer especially when dealing with smaller order quantities or a basket of products. This is where a sourcing partner like Srindhya Global comes in. The firm provides GMP certified pharma products ranging from finished products to API’s and raw materials to wholesalers, distributors and institutional buyers. 

Every shipment is accompanied by a full set of compliance documents. If you are looking for more than just pharma you can also source agricultural and food exports, chemicals, marble/granite, wood products etc. through Srindhya Global which sources from verified Indian manufacturers.

Before placing any pharma order from India, whether through a manufacturer directly or a trade partner, ask for:

  • GMP certificate and manufacturing license copy
  • Certificate of Analysis for the specific batch
  • Drug Master File or Certificate of Pharmaceutical Product where the destination market needs it
  • Stability and shelf-life data
  • Proper cold chain arrangements for temperature-sensitive products

Wrapping Up

Collectively they drive India’s agricultural exporter in India to exceed USD 30 billion per annum to markets in more than 200 countries. Due diligence on certifications, documentation and references before placing an order are important considerations when selecting a pharmaceutical exporting company in India for buyers and partnering with a trade expert who is familiar with the terrain can simplify the process significantly.

FAQS

Have a question before getting in touch? Below are the answers to the queries we hear most often from international B2B buyers. If your question is not covered here, send us a message and our trade team will respond within 24 hours.

Sun Pharmaceutical Industries leads by both revenue and market value, with net annual sales above ₹54,900 crore, followed by Dr. Reddy's Laboratories and Aurobindo Pharma.

India's pharmaceutical exports reached USD 30.47 billion in FY 2024-25, a 9.4% rise over the year before, with the US taking around a third of that total.

Look for GMP certification from CDSCO, along with market-specific approvals such as USFDA, UK MHRA, or EU GMP, depending on where the goods are headed.

Yes, for most pharmaceutical exporters. Pharmexcil registration, along with a valid IEC from the DGFT, forms the base requirement before a shipment can move out of India.

Yes. Many Indian exporters and sourcing partners supply both finished formulations and active pharmaceutical ingredients, which cuts down on the need to manage multiple suppliers for one order.